Loading...

PFE PFIZER INC Management Changes 8-K Filing

PFZR

PF

PFIZER INC

(PFE)

2023 8-K

Show Summary

Show Summary

Debt-Equity Swaps

Cost Realignment

Financial Results

Financial Guidance

Q3 Earnings Report

Results of Operations and F...

Modifications to Compensati...

Departure of Directors

Election of Directors

Cost Reduction Program

Results of Operations and F...

Annual Meeting of Shareholders

Results of Operations and F...

Mini-Tender Offer

Acquisition of Seagen Inc.

Completion of Merger

Regulation FD Disclosure

Commercial Operations Reorg...

Results of Operations and F...

Earnings Update

Results of Operations and F...

Restructuring and reorganis...

Public Offering of Notes

Merger Agreement

Results of Operations and F...

Annual Meeting of Shareholders

Merger Agreement

Relocation of Headquarters

Results of Operations and F...

External Links:

Pfizer Inc. announced a restructuring of its Research and Development organization with Oncology as a stand-alone unit, resulting in the departure of Dr. William Pao and the appointment of Dr. Chris Boshoff and Dr. Mikael Dolsten to new roles.

AI Assistant

PFIZER INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.